Long-term Antiviral Hepatitis C treatment associated with Rods and Ring Cytoplasmic antibodies

Authors

  • Vasile Feldrihan
  • Andreea Benea
  • Monica Lia Junie

DOI:

https://doi.org/10.15386/cjmed-996

Keywords:

hepatitis C virus infection, autoantibodies, rods and ring pattern

Abstract

Aim. Clinical description of a patient diagnosed with chronic hepatitis C virus infection, which associated a rare anti-cytoplasmic pattern, known as "Rods and Ring".

Method. Clinical case report.

Results. A 76-year old female patient with chronic hepatitis C virus infection under treatment for several months with pegylated Interferon-Ribavirin (started eight months ago) presented for clinical and biological evaluation of the therapeutic response.

Conclusion. This is the first reported clinical case of a patient with cytoplasmic filamentous rods and rings autoantibodies associated with chronic hepatis C from the Clinical Hospital IRGH Prof. Dr. O. Fodor Cluj-Napoca, Romania. The presence of these antibodies appears to be triggered by antiviral therapy. Although these are newly identified antibodies, they could be used as serological markers for detecting patients at risk of developing associated autoimmune pathologies or nonresponders to the antiviral therapy. Likewise, their detection could identify patients with occult hepatitis C infection.

Author Biographies

Vasile Feldrihan, UMF Iuliu Hatieganu Cluj-Napoca

Functional Biosciences, Immunology and Allergy

Andreea Benea, Immunology Laboratory of Hospital IRGH Prof. Dr. O. Fodor Cluj-Napoca

Immunology

Monica Lia Junie, UMF Iuliu Hatieganu Cluj-Napoca

Molecular Sciences, Microbiology

Downloads

Additional Files

Published

2019-01-27

How to Cite

1.
Feldrihan V, Benea A, Junie ML. Long-term Antiviral Hepatitis C treatment associated with Rods and Ring Cytoplasmic antibodies. Med Pharm Rep [Internet]. 2019 Jan. 27 [cited 2025 Oct. 5];92(1):87-90. Available from: https://medpharmareports.com/index.php/mpr/article/view/996

Issue

Vol. 92 No. 1 (2019)

Section

Case Report

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.